• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ULTHERA, INC., MERZ DEVICE INNOVATION CENTER THE CELLFINA SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ULTHERA, INC., MERZ DEVICE INNOVATION CENTER THE CELLFINA SYSTEM Back to Search Results
Model Number CM-1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Contusion (1787); Swelling (2091); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
The treating provider stated on (b)(6) 2018 that the device performed as intended during the treatment.A follow up was made on (b)(6) 2018, with no response to date regarding the serial numbers of the devices used during the treatment and the patient's current resolution status.When additional information becomes available regarding this event, a supplemental medwatch form will be submitted.
 
Event Description
Merz device innovation center was made aware via email of a reported adverse event on (b)(6) 2018.A patient reported bruising, swelling, dents, ripples/bulges, and "red and obvious" incision sites post cellfina treatment.The treatment was reported to have occured on (b)(6) 2017.The treating practice stated that the patient was treated with hyaluronic acid filler in an attempt to mitigate or resolve the reported adverse events.
 
Manufacturer Narrative
The lot number of the disposable kit was not provided.No malfunctions of the device were alleged nor identified during the investigation.As the disposables kit was discarded and the motor module does not have direct contact with the patient, no devices were requested to be returned for evaluation.A review of the dhr found that this motor module was not subject to any rework prior to release.The patient alleged that areas of "fat herniation" would be treated with tempsure and sculpsure in (b)(6) 2018, but confirmation that procedures occurred was not provided.A review of the complaint trend report for "bruising", "edema", "skin surface convexity, depression or other irregularity", and "redness, erythema or rash" for the month of (b)(6) 2019 found that a trend has not been identified.The investigation found that there are not enough details to confirm whether a merz/ulthera device malfunctioned.It is unconfirmed whether a merz/ulthera device caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THE CELLFINA SYSTEM
Type of Device
THE CELLFINA SYSTEM
Manufacturer (Section D)
ULTHERA, INC., MERZ DEVICE INNOVATION CENTER
1840 south stapley drive
suite 200
mesa AZ 85204
MDR Report Key7469942
MDR Text Key106792895
Report Number3006560326-2018-00002
Device Sequence Number1
Product Code OUP
Combination Product (y/n)N
PMA/PMN Number
K161885
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 04/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCM-1
Device Catalogue NumberCM-1
Was the Report Sent to FDA? No
Date Manufacturer Received04/06/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age27 YR
Patient Weight59
-
-